155 related articles for article (PubMed ID: 23857892)
1. Aldehyde oxidase 1 (AOX1) in human liver cytosols: quantitative characterization of AOX1 expression level and activity relationship.
Fu C; Di L; Han X; Soderstrom C; Snyder M; Troutman MD; Obach RS; Zhang H
Drug Metab Dispos; 2013 Oct; 41(10):1797-804. PubMed ID: 23857892
[TBL] [Abstract][Full Text] [Related]
2. Absolute quantification of aldehyde oxidase protein in human liver using liquid chromatography-tandem mass spectrometry.
Barr JT; Jones JP; Joswig-Jones CA; Rock DA
Mol Pharm; 2013 Oct; 10(10):3842-9. PubMed ID: 24006961
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
[TBL] [Abstract][Full Text] [Related]
4. Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase.
Choughule KV; Joswig-Jones CA; Jones JP
Biochem Pharmacol; 2015 Aug; 96(3):288-95. PubMed ID: 26032640
[TBL] [Abstract][Full Text] [Related]
5. A novel ring oxidation of 4- or 5-substituted 2H-oxazole to corresponding 2-oxazolone catalyzed by cytosolic aldehyde oxidase.
Arora VK; Philip T; Huang S; Shu YZ
Drug Metab Dispos; 2012 Sep; 40(9):1668-76. PubMed ID: 22621803
[TBL] [Abstract][Full Text] [Related]
6. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous absolute protein quantification of carboxylesterases 1 and 2 in human liver tissue fractions using liquid chromatography-tandem mass spectrometry.
Sato Y; Miyashita A; Iwatsubo T; Usui T
Drug Metab Dispos; 2012 Jul; 40(7):1389-96. PubMed ID: 22504157
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues.
Chen S; Austin-Muttitt K; Zhang LH; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2019 Oct; 371(1):75-86. PubMed ID: 31289113
[TBL] [Abstract][Full Text] [Related]
9. Molecular Cloning and Characterization of Marmoset Aldehyde Oxidase.
Uehara S; Uno Y; Okamoto E; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2017 Aug; 45(8):883-886. PubMed ID: 28487309
[TBL] [Abstract][Full Text] [Related]
10. A single amino acid substitution confers high cinchonidine oxidation activity comparable with that of rabbit to monkey aldehyde oxidase 1.
Fukiya K; Itoh K; Yamaguchi S; Kishiba A; Adachi M; Watanabe N; Tanaka Y
Drug Metab Dispos; 2010 Feb; 38(2):302-7. PubMed ID: 19910515
[TBL] [Abstract][Full Text] [Related]
11. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
Zientek M; Jiang Y; Youdim K; Obach RS
Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
[TBL] [Abstract][Full Text] [Related]
12. In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor.
Zhang X; Liu HH; Weller P; Zheng M; Tao W; Wang J; Liao G; Monshouwer M; Peltz G
Pharmacogenomics J; 2011 Feb; 11(1):15-24. PubMed ID: 20177421
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues.
Hammid A; Fallon JK; Vellonen KS; Lassila T; Reinisalo M; Urtti A; Gonzalez F; Tolonen A; Smith PC; Honkakoski P
Eur J Pharm Sci; 2023 Dec; 191():106603. PubMed ID: 37827455
[TBL] [Abstract][Full Text] [Related]
14. Identification of aldehyde oxidase as the neonicotinoid nitroreductase.
Dick RA; Kanne DB; Casida JE
Chem Res Toxicol; 2005 Feb; 18(2):317-23. PubMed ID: 15720138
[TBL] [Abstract][Full Text] [Related]
15. Substrate selectivity of human aldehyde oxidase 1 in reduction of nitroaromatic drugs.
Ogiso T; Fukami T; Mishiro K; Konishi K; Jones JP; Nakajima M
Arch Biochem Biophys; 2018 Dec; 659():85-92. PubMed ID: 30367827
[TBL] [Abstract][Full Text] [Related]
16. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
Sugihara K; Kitamura S; Tatsumi K
Drug Metab Dispos; 1996 Feb; 24(2):199-202. PubMed ID: 8742231
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.
Choughule KV; Barr JT; Jones JP
Drug Metab Dispos; 2013 Oct; 41(10):1852-8. PubMed ID: 23918666
[TBL] [Abstract][Full Text] [Related]
18. Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injury.
Amano T; Fukami T; Ogiso T; Hirose D; Jones JP; Taniguchi T; Nakajima M
Biochem Pharmacol; 2018 May; 151():69-78. PubMed ID: 29522712
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde oxidase activity in donor-matched fresh and cryopreserved human hepatocytes and assessment of variability in 75 donors.
Hutzler JM; Yang YS; Brown C; Heyward S; Moeller T
Drug Metab Dispos; 2014 Jun; 42(6):1090-7. PubMed ID: 24713130
[TBL] [Abstract][Full Text] [Related]
20. Expression of the theta class GST isozyme, YdfYdf, in low GST dogs.
Watanabe T; Ohashi Y; Kosaka T; Arakawa S; Shibaya Y; Yamoto T; Manabe S; Takasaki W
Arch Toxicol; 2006 May; 80(5):250-7. PubMed ID: 16237518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
